Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Taneja

Showing results (351-360 of 845) with videos related to

Pageof 85
Sort By:
The Journal of Urology|February 14, 2014
Re: plasma phospholipid fatty acids and prostate cancer risk in the SELECT trialSamir S Taneja
The Journal of Urology|August 13, 2019
Re: Trend of Adverse Stage Migration in Patients Treated with Radical Prostatectomy for Localized Prostate CancerSamir S Taneja
The Journal of Urology|August 13, 2019
Re: Association of Treatment with 5α-Reductase Inhibitors with Time to Diagnosis and Mortality in Prostate CancerSamir S Taneja
The Journal of Urology|May 20, 2015
Re: Patterns of declining use and the adverse effect of primary androgen deprivation on all-cause mortality in elderly men with prostate cancerSamir S Taneja
The Journal of Urology|May 20, 2015
Re: Intense androgen-deprivation therapy with abiraterone acetate plus leuprolide acetate in patients with localized high-risk prostate cancer: results of a randomized phase II neoadjuvant studySamir S Taneja
The Journal of Urology|April 22, 2015
Re: The Impact of fellowship training on pathological outcomes following radical prostatectomy: a population based analysisSamir S Taneja
The Journal of Urology|August 2, 2016
Re: Gleason Misclassification Rate is Independent of Number of Biopsy Cores in Systematic BiopsySamir S Taneja
The Journal of Urology|August 2, 2016
Re: Focal Ablation Targeted to the Index Lesion in Multifocal Localised Prostate Cancer: A Prospective Development StudySamir S Taneja
The Journal of Urology|June 20, 2015
Re: Can Urinary PCA3 Supplement PSA in the Early Detection of Prostate Cancer?Samir S Taneja
The Journal of Urology|July 22, 2015
Re: Improving the Specificity of Screening for Lethal Prostate Cancer Using Prostate-Specific Antigen and a Panel of Kallikrein Markers: A Nested Case-Control StudySamir S Taneja
Pageof 85

Showing results (351-360 of 845) with videos related to

Sort By:
Pageof 85
The Journal of Urology|February 14, 2014
Re: plasma phospholipid fatty acids and prostate cancer risk in the SELECT trialSamir S Taneja
The Journal of Urology|August 13, 2019
Re: Trend of Adverse Stage Migration in Patients Treated with Radical Prostatectomy for Localized Prostate CancerSamir S Taneja
The Journal of Urology|August 13, 2019
Re: Association of Treatment with 5α-Reductase Inhibitors with Time to Diagnosis and Mortality in Prostate CancerSamir S Taneja
The Journal of Urology|May 20, 2015
Re: Patterns of declining use and the adverse effect of primary androgen deprivation on all-cause mortality in elderly men with prostate cancerSamir S Taneja
The Journal of Urology|May 20, 2015
Re: Intense androgen-deprivation therapy with abiraterone acetate plus leuprolide acetate in patients with localized high-risk prostate cancer: results of a randomized phase II neoadjuvant studySamir S Taneja
The Journal of Urology|April 22, 2015
Re: The Impact of fellowship training on pathological outcomes following radical prostatectomy: a population based analysisSamir S Taneja
The Journal of Urology|August 2, 2016
Re: Gleason Misclassification Rate is Independent of Number of Biopsy Cores in Systematic BiopsySamir S Taneja
The Journal of Urology|August 2, 2016
Re: Focal Ablation Targeted to the Index Lesion in Multifocal Localised Prostate Cancer: A Prospective Development StudySamir S Taneja
The Journal of Urology|June 20, 2015
Re: Can Urinary PCA3 Supplement PSA in the Early Detection of Prostate Cancer?Samir S Taneja
The Journal of Urology|July 22, 2015
Re: Improving the Specificity of Screening for Lethal Prostate Cancer Using Prostate-Specific Antigen and a Panel of Kallikrein Markers: A Nested Case-Control StudySamir S Taneja
Pageof 85